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unhealthy	 diets	 contribute	 to	 this	 trend,	 the	 global	 rise	
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able	 to	address	causality	and	mechanistic	studies	can	be	 limited	by	the	 lack	of	
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diabetes	mellitus	[GDM]),	is	associated	with	long-	term	ef-
fects	on	offspring	health	such	as	increased	risk	of	obesity,	











2 	 | 	 ANIMAL MODELS OF 
MATERNAL OBESITY
2.1	 |	 Why animals?
Human	 epidemiology	 studies	 are	 vital	 in	 identifying	 as-
sociations	 between	 intrauterine	 insults	 and	 long-	term	
offspring	outcome.	However,	 it	 is	 challenging	 to	demon-
strate	causal	relationships	in	such	studies,	and	they	are	not	











for	 their	 similarities	 to	 humans	 with	 respect	 to	 maturity	
at	birth	as	well	as	 the	ability	 to	carry	out	complex	 foetal	
physiology	 studies.4,5  Nevertheless,	 rodent	 models	 are	
often	preferred	due	to	their	relatively	short	gestation	and	
lifespan	thus	allowing	experiments	across	the	life-	course.	




cardiometabolic	 disease,	 converging	 on	 offspring	 adipos-
ity,	insulin	resistance	and	hypertension	(Figure 1).2
2.2	 |	 Types of animal models
There	are	several	ways	to	study	programming	by	mater-
nal	obesity	or	GDM	in	rodent	models.	Genetic	models	of	
obesity	 can	 be	 used,	 such	 as	 the	 Leprdb/+	 model,	 where	




impact	as	 they	do	not	 reflect	 common	causes	of	human	
obesity.	Alternatively,	maternal	obesity	can	be	induced	by	





diet,	 either	 initiated	 before	 gestation	 to	 induce	 pre-	
conception	obesity7	or	closer	 to	conception.8 The	timing	










dows.2	 Experimental	 diets	 include	 high-	fat	 diets	 (HFD),	
usually	ranging	from	40%	to	60%	kcals	from	fat.9,10	Despite	
their	ability	to	introduce	metabolic	alterations,	HFD	pel-
lets	 are	 less	 palatable	 than	 chow	 and	 HFD-	fed	 rodents	








However,	 models	 specific	 for	 maternal	 hyperglycaemia/
Novelty statement




•	 Animal	 models	 help	 to	 define	 causal	 mecha-
nisms	underlying	the	long-	term	effects	of	devel-
opment	in	an	in utero	obesogenic	environment.
•	 This	 review	 highlights	 the	 importance	 of	 ani-
mal	models	in	studying	the	long-	term	age-	and	
sex-	dependent	 effects	 of	 maternal	 obesity	 and	
potential	 clinically	 relevant	 interventions	 on	
offspring	outcome.





diabetic’	 mouse	 or	 by	 injection	 of	 wild-	type	 mice	 with	
streptozotocin,	 a	 toxin	 that	 preferentially	 attacks	 pancre-
atic	β-	cells	(reviewed	in	Vambergue	et	al.6).	Some	models	
show	normal	or	mildly	altered	glucose	homeostasis	before	
mating	 but	 develop	 into	 full-	blown	 diabetes	 when	 preg-
nant.	These	include	models	of	streptozotocin	injections	at	
a	later	timepoint	in	gestation	and	the	Leprdb/+	mouse.6




position	 is	 adversely	 affected	 by	 exposure	 to	 an	 obese	
environment	 in utero.	 A	 meta-	analysis	 looking	 at	 vari-
ous	 animal	 models	 of	 maternal	 pre-	conception	 obesity	
found	 significantly	 increased	 body	 weight	 (123  studies,	
n  =  5772),	 body	 fat	 percentage	 (32  studies,	 n  =  1284)	
and	 absolute	 fat	 mass	 (10  studies,	 n  =  205)	 in	 off-
spring	 of	 obese	 pregnancy.	 Importantly,	 all	 offspring	
were	 fed	 healthy	 chow	 postnatally,	 and	 the	 association	
held	 true	 when	 stratified	 by	 sex,	 species	 and	 offspring	







hyperplasia	 have	 been	 implicated	 in	 the	 developmental	
programming	of	 later	obesity	by	maternal	overnutrition	
or	 GDM	 in	 rodent	 models	 and	 occurs	 prior	 to	 changes	
in	body	weight.2,14	Exposure	to	maternal	obesity	can	in-
troduce	 permanent	 changes	 in	 adipose	 tissue	 function	
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as	well	as	mass.	Rat	offspring	of	dams	fed	a	HFD	before	
and	 during	 pregnancy	 (but	 not	 lactation)	 developed	 al-
terations	in	both	the	plasma	and	adipose	tissue	lipidome	
characterised	by	elevated	circulating	triglycerides	despite	
de novo	 lipogenesis,	 suggesting	 inability	 of	 the	 adipose	
tissue	to	adequately	store	lipid.15	Interestingly,	offspring	
adiposity	and	adipose	tissue	dysfunction	may	not	be	pro-
grammed	 in	 the	 same	 critical	 developmental	 window:	
male	offspring	of	mice	fed	a	HFD	pre-	pregnancy	showed	
exaggerated	 adiposity	 when	 challenged	 with	 a	 HFD	 in	
adulthood,	 whereas	 age-	matched	 offspring	 from	 dams	
where	the	HFD	was	continued	in	pregnancy	showed	adi-
pose	 tissue	 inflammation	 and	 glucose	 intolerance	 with-
out	differences	in	fat	mass.16
Altered	 energy	 homeostasis	 likely	 contributes	 to	 ad-
iposity	 in	 offspring	 of	 obese	 pregnancy.	 A	 rat	 study	 of	
maternal	 HFHS-	induced	 obesity	 in	 pregnancy	 and	 lac-
tation	 showed	 adiposity	 and	 basal	 hyperphagia	 in	 both	






tides	 (NPY	 and	 AgRP)	 and	 downregulation	 of	 anorexi-
genic	peptides	(POMC)	in	the	hypothalamus	of	offspring	
exposed	 to	 maternal	 overnutrition	 have	 been	 reported	
(reviewed	 in	 Dearden	 et	 al.19).	 Additionally,	 offspring	
of	obese	rat	dams	exhibit	resistance	to	the	appetite	sup-
pressing	 and	 hypothalamic	 signalling	 effects	 of	 leptin	
that	may	contribute	 to	 the	development	of	hyperphagia	
and	obesity.17
3.2	 |	 Type 2 Diabetes












point	 they	 developed	 glucose	 intolerance.14  Moreover,	










content	 without	 differences	 in	 glucose.	 By	 6  months	 of	
age,	they	had	developed	a	type	2	diabetes-	like	phenotype	
with	 decreased	 serum	 and	 pancreatic	 insulin	 resulting	
in	 fasting	 hyperglycaemia,	 indicative	 of	 β-	cell	 exhaus-
tion	 and	 insulin	 secretory	 impairment.7	 Unlike	 males,	
6-	month-	old	 female	 offspring	 had	 increased	 pancreatic	
insulin	 content	 and	 a	 comparable	 glucose	 tolerance	 to	
controls,	 suggesting	sexual	dimorphism	in	 the	 timing	of	
programmed	 outcomes.7	 Defects	 in	 insulin	 secretory	 ca-
pacity	may	be	programmed	directly	by	maternal	obesity.	
A	 study	 of	 maternal	 HFHS-	induced	 obesity	 found	 signs	
of	 islet	malfunction	 in	8-	week-	old	male	offspring.	These	
mice	 maintained	 normal	 glucose-	stimulated	 insulin	 se-
cretion	 at	 this	 age,	 but	 underlying	 defects	 detected	 may	
predispose	 to	 future	 β-	cell	 failure.20	 Consistent	 with	 the	
sex	differences	in	6-	month-	old	offspring	described	above,	
an	 improvement	 in	 islet	 function	 was	 observed	 in	 fe-
male	offspring,	suggesting	that	exposure	to	an	intrauter-
ine	obesogenic	environment	may	have	prepared	 females	
for	 a	 nutrient-	rich	 postnatal	 life,	 at	 least	 in	 the	 short	
term.20  Whether	 this	 protection	 is	 long-	lived	 remains	
unclear,	 since	 glucose-	stimulated	 insulin	 secretion	 was	
decreased	 in	 9-	month-	old	 female	 offspring	 of	 HFD-	fed	
rats.21 Maternal	obesity	therefore	increases	type	2	diabe-
tes	 risk	 by	 affecting	 both	 insulin	 resistance	 and	 insulin	
secretion.
3.3	 |	 Cardiovascular disease
The	aforementioned	meta-	analysis	of	pre-	conception	ma-
ternal	 obesity	 models	 also	 found	 a	 significant	 increase	
in	 offspring	 systolic	 blood	 pressure	 by	 tail	 cuff	 plethys-
mography	 (9  studies,	 n  =  251)	 as	 well	 as	 dyslipidaemia	
(elevated	triglycerides	[46 studies,	n = 1337],	total	choles-
terol	 [27  studies,	n = 795]	and	LDL-	cholesterol	 [4  stud-
ies,	n = 158	animals])	independent	of	species,	sex	or	age.12	
Since	hypertension	and	dyslipidaemia	are	both	independ-
ent	 risk	 factors	 for	 cardiovascular	 disease,	 this	 suggests	
maternal	obesity	can	program	predisposition	not	only	to	
type	 2	 diabetes,	 but	 cardiovascular	 pathologies	 as	 well.	
Alongside	adiposity,	3-	and	6-	month-	old	mouse	offspring	
exposed	 to	 maternal	 HFHS-	induced	 obesity	 showed	 el-
evated	 systolic	 and	 diastolic	 blood	 pressure	 in	 the	 dark	
(active)	 phase.7	 Although	 adiposity	 is	 a	 risk	 factor	 for	
hypertension,	changes	in	offspring	BP	often	precede	off-
spring	obesity	and	thus	seem	independently	programmed.	
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HFHS-	induced	 obesity	 increased	 left	 ventricular	 weight	
in	8-	week-	old	male	and	female	offspring.23	Studies	using	
a	 similar	 mouse	 model	 found	 increased	 heart	 weight	 as	
early	 as	 3  weeks	 of	 age	 in	 male	 offspring,	 accompanied	
by	 increased	 cardiomyocyte	 size	 and	 re-	expression	 of	
foetal	cardiac	genes,	 indicative	of	pathological	hypertro-
phy.24  This	 occurred	 before	 the	 development	 of	 obesity,	
suggesting	 direct	 cardiovascular	 programming	 by	 ma-
ternal	 obesity	 independently	 of	 postnatal	 adiposity,	 and	
these	changes	may	persist	throughout	life	as	this	pheno-
type	was	also	observed	at	8 weeks	of	age.24	Accordingly,	
cardiac	 morphological	 changes	 were	 also	 an	 early	 phe-
notype	in	sheep	foetuses	exposed	to	gestational	overfeed-
ing.4 With	regard	to	function,	ex vivo	assessment	of	heart	
function	 using	 the	 isolated	 Langendorff	 heart	 perfusion	





3.4	 |	 The effect of age
Programmed	 differences	 in	 adiposity	 and	 glucose	 toler-
ance	 have	 been	 shown	 to	 become	 greater	 with	 age.	 For	
instance,	 female	 offspring	 of	 non-	obese	 HFD-	fed	 rats	







this	 model.7	 Similarly,	 despite	 normal	 glucose	 tolerance	
for	the	first	3 months	of	life,	both	male	and	female	mouse	
offspring	of	dams	fed	a	HFD	from	2 weeks	pre-	conception	
developed	 glucose	 intolerance	 by	 36  weeks,	 which	 per-
sisted	until	52 weeks	of	age	and	was	accompanied	by	hy-
perinsulinaemia	 and	 whole-	body	 insulin	 resistance.26,27	
Both	basal	and	stimulated	hepatic	glucose	output	were	in-
creased	throughout	life	but	drastically	increased	between	
12	 and	 24  weeks	 of	 age	 in	 female	 offspring	 of	 HFD-	fed	
dams,	 clearly	 showing	 an	 ageing	 effect.27  Moreover,	




in	 whole-	body	 insulin	 resistance	 observed	 later	 in	 life.27	
A	different	murine	study	of	maternal	HFD	feeding	with-




Although	 body	 weight,	 fat	 mass	 and	 glucose	 toler-
ance	were	not	altered	in	in	8-	week-	old	male	offspring	of	
HFHS-	induced	 obese	 mouse	 pregnancy,22,24	 they	 devel-
oped	 increased	 adiposity	 and	 metabolic	 abnormalities	
by	6 months	of	age.29 These	6-	month-	old	male	offspring	





of	 maternal	 obesity	 (rather	 than	 gestational	 HFD	 feed-
ing)	in	offspring	aged	for	12 months	or	longer.	A	study	in	
rats	showed	that	both	male	and	female	offspring	of	obese	
dams	 showed	 excessive	 age-	related	 adiposity,	 insulin	 re-







offspring	 were	 heavier	 as	 adults	 (12  weeks)	 but	 reached	





of	 immunological	 ageing.	 In	 another	 study	 of	 maternal	
overfeeding,	increased	fur	thinning	and	markers	of	oste-
oporosis	were	 indicative	of	accelerated	ageing	 in	 female	
offspring	of	HFD-	fed	mice.9
4 	 | 	 FACTORS MEDIATING 
EFFECTS OF MATERNAL OBESITY
Several	 factors	 may	 mediate	 developmental	 program-
ming	by	maternal	obesity,	including	diet	and	lipids,	glu-
cose	 homeostasis	 and	 hyperinsulinaemia,	 adipokines,	
inflammation,	placental	dysfunction	and	oxidative	stress	
(Figure 1).
6 of 11 |   SCHOONEJANS and OZANNE
4.1	 |	 Maternal diet
Feeding	pregnant	rats	a	‘junk	food’	diet	from	conception	
(thus	 avoiding	 pre-	conception	 obesity)	 to	 weaning	 in-
duced	obesity	and	altered	food	preferences	in	10-	week-	old	
offspring,	illustrating	the	influence	of	maternal	diet	dur-




indicating	 a	 role	 for	 dietary	 lipid	 specifically	 including	
potential	direct	effects	of	the	in utero	milieu	on	the	foetus	
that	are	independent	of	maternal	obesity.8	Indeed,	a	study	
comparing	 offspring	 of	 dams	 fed	 HFD	 without	 obesity	
(HFD	in	pregnancy	and	lactation	only)	to	offspring	of	pre-	
conception	 obese	 HFD-	fed	 dams	 found	 comparable	 de-
grees	of	obesity	and	hyperinsulinaemia	in	adult	offspring	







4.2	 |	 Glucose homeostasis
Maternal	 fasting	 insulin	 (but	 not	 lipids	 or	 adiposity)	
directly	 correlates	 with	 insulin	 in	 8-	week-	old	 male	
offspring	 from	 HFHS-	fed	 obese	 mouse	 dams,	 point-
ing	 towards	a	key	 role	 for	maternal	hyperinsulinaemia	
in	 the	 programming	 of	 offspring	 type	 2	 diabetes	 risk.33	
Accordingly,	 intrauterine	exposure	 to	maternal	genetic	
insulin	resistance	 (without	maternal	obesity	or	glucose	
intolerance)	 induces	 hyperinsulinaemia,	 insulin	 resist-
ance	 and	 glucose	 intolerance	 and	 fatty	 liver	 disease	 in	
wild-	type	 offspring.34  These	 offspring	 did	 not	 show	
changes	 in	body	weight	or	adiposity	up	 to	6 months	of	
age,	 suggesting	 factors	 other	 than	 maternal	 hyperinsu-
linaemia	 or	 insulin	 resistance	 were	 responsible	 for	 the	
programming	 of	 obesity.34	 Direct	 effects	 of	 maternal	
insulin	on	the	developing	foetus	are	unlikely	as	insulin	
does	 not	 cross	 the	 placenta.	 Programming	 effects	 may	
instead	 occur	 secondary	 to	 increased	 placental	 insulin	
signalling,	which	could	promote	placental	 lipid	deposi-
tion	as	well	as	directly	alter	placental	function.33	In	ad-
dition,	 enhanced	 placental	 transfer	 of	 glucose	 (which	
freely	 crosses	 the	 placenta)	 in	 hyperglycaemic	 preg-
nancies	 stimulates	 foetal	 insulin	 secretion,	 leading	 to	
fat	accretion	and	consequent	adiposity	as	seen	in	foetal	
rhesus	monkeys	chronically	infused	with	insulin	in	late	
gestation	at	a	concentration	similar	 to	 that	expected	 in	
human	 diabetic	 pregnancy.35  Maternal	 hyperglycae-
mia	 may	 also	 contribute	 to	 cardiovascular	 disease	 risk	
in	 offspring.	 Neonatal	 rat	 offspring	 of	 both	 HFD-	fed	
and	 streptozotocin-	injected	 dams	 displayed	 cardiac	
dysfunction,	 but	 offspring	 exposed	 to	 the	 combination	
of	 maternal	 HFD	 feeding	 and	 diabetes	 had	 the	 most	






Maternal	 obesity	 is	 associated	 with	 excess	 circulating	
levels	of	the	adipokine	leptin,	as	is	also	seen	in	animal	
models	of	obese	pregnancy.7,13	Late	gestation	leptin	in-
fusion	 in	 foetal	 sheep	 led	 to	 alterations	 in	 adipose	 tis-
sue	 morphology	 and	 transcriptome,	 indicating	 effects	
of	 leptin	 on	 developing	 adipose	 tissue.5	 Leptin	 admin-
istration	 in	mid-	gestation	was	recently	shown	to	affect	
placental	size	and	transcriptome,	suggesting	leptin	may	
also	 influence	 foetal	 development	 through	 actions	 on	
the	placenta.36	 In	adults,	 leptin	suppresses	 food	 intake	
and	 promotes	 energy	 expenditure	 through	 actions	 on	
the	hypothalamus.	Leptin	levels	in	rodents	rise	sharply	
in	the	second	week	of	postnatal	life,	giving	rise	to	a	‘ne-




cuits	 involved	 in	 food	 intake.19	Abnormal	 leptin	 levels	
in	 offspring	 exposed	 to	 maternal	 obesity,	 such	 as	 the	
prolonged	 and	 exaggerated	 leptin	 surge	 observed	 in	
offspring	 of	 HFHS-	fed	 obese	 dams,	 may	 thus	 lead	 to	
permanent	 changes	 in	 hypothalamic	 control	 of	 energy	
balance.17	Like	maternal	obesity,	neonatal	leptin	injec-
tions	also	increased	offspring	BP	in	adulthood,	suggest-
ing	 alterations	 in	 the	 leptin	 surge	 may	 program	 both	
hyperphagia	 and	 hypertension	 by	 driving	 sympathetic	
hyperactivation	 in	 the	 brain	 independent	 of	 its	 effects	
on	food	intake	and	obesity.37
4.4	 |	 Inflammation, hypoxia and 
oxidative stress
Obese	pregnancy	is	associated	with	elevated	levels	of	in-
flammatory	 markers	 in	 serum	 and	 adipose	 tissue,	 indi-
cating	dams	enter	pregnancy	in	a	pro-	inflammatory	state	
that	 may	 be	 transmitted	 to	 the	 fetus.38	 Accordingly,	 in-
flammatory	 markers	 are	 also	 found	 in	 the	 placenta	 and	










restriction.38	 Furthermore,	 levels	 of	 hypoxia-	inducible	
factor	 1	 alpha	 were	 elevated	 in	 late	 gestation	 placentas	
from	obese	mouse	pregnancies	and	correlated	with	ma-
ternal	 insulin,	suggesting	a	direct	effect	of	the	maternal	
metabolic	 state	 on	 placental	 function.33	 Intrauterine	
hypoxia	 likely	 contributes	 to	 adverse	 outcomes	 in	 off-





oxidative	 stress,	 since	 supplementation	 of	 antioxidants	
during	 maternal	 hypoxia	 ameliorates	 offspring	 out-
comes.39	Placentas	of	obese	mouse	dams	show	excess	lipid	
deposition,	thus	increasing	the	risk	of	placental	oxidative	







5 	 | 	 INTERVENTION STRATEGIES
The	concept	of	DOHaD	offers	a	new	and	early	interven-
tion	 window	 for	 the	 prevention	 of	 non-	communicable	




is	especially	 important	 to	break	 the	vicious	cycle	of	ma-
ternal	 obesity,	 referring	 to	 the	 effect	 that	 daughters	 of	
obese	mothers	are	at	increased	risk	of	being	obese	in	preg-
nancy	 themselves	 due	 to	 developmental	 programming	
and	 therefore	 potentially	 transmit	 poor	 cardiometabolic	
health	to	their	children.	Clinically	relevant	interventions	
aim	 to	 target	 the	abovementioned	programming	 factors,	
with	 most	 studies	 focusing	 on	 improving	 maternal	 gly-
caemia,	 insulin	 sensitivity	 and/or	 weight.	 These	 can	 be	
broadly	classified	into	lifestyle	and	pharmaceutical	inter-
ventions	(Figure 1).









placing	 mothers	 on	 a	 healthy	 diet	 for	 a	 few	 months	 be-
fore	pregnancy	attenuated	the	maternal	insulin	response	
to	a	glucose	 tolerance	 test	 (in	 the	absence	of	changes	 in	
body	weight),	prevented	foetal	growth	restriction	and	sig-
nificantly	attenuated	the	increase	in	foetal	hepatic	triglyc-
erides	 and	 gluconeogenic	 gene	 expression.40  These	 data	
demonstrate	 that	 the	pre-	conception	and	early	postnatal	
periods,	in	addition	to	pregnancy	itself,	are	promising	time	
windows	 for	 early	 life	 intervention.	 However,	 although	
pair-	feeding	 hyperphagic	 Leprdb/+	 mice	 to	 wild-	type	
dams	improved	maternal	and	foetal	outcomes,	restricting	




intervention.	 Gestational	 dietary	 supplementation	 with	
the	antioxidant	Quercetin	 in	a	murine	diet-	induced	ma-
ternal	 obesity	 model	 attenuated	 the	 hyperinsulinaemia,	
hyperglycaemia,	 obesity	 and	 hypertension	 observed	 in	
female	 offspring,9	 and	 antioxidant	 supplementation	 to	
Western	(but	not	control)	diet-	fed	rat	dams	decreased	off-
spring	adiposity,	 leptin	and	insulin	 levels,	and	 improved	
glucose	 tolerance.14	 Interestingly,	 the	 latter	 intervention	
prevented	maternal	hyperinsulinaemia	but	did	not	affect	
maternal	body	composition,	indicating	that	programming	
effects	 can	 be	 prevented	 without	 changes	 in	 maternal	
adiposity.14
5.1.2	 |	 Exercise	interventions
Moderate	 exercise	 during	 obese	 pregnancy	 can	 cor-
rect	 placental	 hypoxia,	 maternal	 insulin	 levels	 and	 glu-




prevented	 the	 cardiac	 hypertrophy	 and	 LV	 dysfunction	
observed	 in	 offspring	 of	 untreated	 obese	 dams	 through	
improved	 calcium	 homeostasis	 and	 cardiac	 contractil-
ity.22,33	 Interestingly,	 the	 exercise	 intervention	 had	 no	
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effect	 on	 offspring	 blood	 pressure.22	 Cardiac	 function	
and	 blood	 pressure	 may	 thus	 be	 programmed	 through	
different	mechanisms	and	will	therefore	likely	need	dif-
ferent	 intervention	 strategies	 to	 correct	 them.	 Maternal	
exercise	 was	 also	 shown	 to	 prevent	 adiposity	 and	 he-
patic	 steatosis	 in	 4-	month-	old	 offspring	 of	 Western-	diet	
fed	 obese	 mouse	 dams.42	 Gestational	 exercise	 also	 pre-
vented	 the	 hyperinsulinaemia	 and	 insulin	 resistance	
observed	 in	 12-	month-	old	 female	 mouse	 offspring	 of	





tiated	 2-	week	 pre-	gestation,	 illustrating	 the	 importance	
of	the	timing	of	interventions.26,27
Lifestyle	interventions	are	extremely	useful	since	they	
are	 affordable	 and	 easy	 to	 implement.	 However,	 poor	
compliance	 in	 humans	 means	 these	 often	 lead	 to	 only	
modest	 improvement	 in	 maternal	 body	 weight	 or	 met-
abolic	 health,	 and	 differences	 in	 offspring	 obesity	 risk	
can	 disappear	 with	 time.	 Therefore,	 research	 has	 ad-
dressed	potential	pharmacological	interventions,	such	as	
metformin.
5.2	 |	 Metformin intervention
Metformin	 is	 an	 oral	 glucose-	lowering	 agent	 that	 is	 in-
creasingly	used	in	type	2	diabetes-	and	GDM-	complicated	
pregnancies	where	glucose	levels	cannot	be	controlled	by	
lifestyle	 alone.43  Metformin	 is	 an	 attractive	 candidate	 to	
prevent	programming	by	maternal	obesity	as	it	is	cheaper	
and	easier	to	administrate	than	insulin,	limits	weight	gain	
in	 humans,	 has	 anti-	inflammatory	 and	 vasculoprotec-
tive	 effects	 and	 may	 reduce	 oxidative	 stress.43	 However,	
metformin	readily	crosses	the	placenta,	and	although	the	





not	 be	 reported	 on	 for	 many	 years.	 Animal	 models	 are	
therefore	crucial	to	explore	such	long-	term	consequences.
Treatment	 with	 a	 clinically	 relevant	 dose	 of	 met-
formin	 during	 pregnancy	 improved	 maternal	 meta-
bolic	 health	 and	 placental	 function	 in	 a	 mouse	 model	
of	diet-	induced	obesity	but	did	not	rescue	foetal	growth	
restriction.44  To	 date,	 few	 studies	 have	 published	 met-
abolic	 outcomes	 in	 adult	 offspring	 exposed	 prenatally	
to	 metformin,	 and	 with	 conflicting	 results.	 Salomäki	
et	 al.	 provided	 metformin	 during	 chow-	fed	 pregnancy	
and	 found	 that	metformin	 introduced	IUGR	at	E18.5.45	






A	 follow-	up	 study	 by	 the	 same	 group	 found	 that	 when	
metformin	was	given	to	pregnant	obese	dams	fed	a	HFD	
before	and	during	pregnancy	(but	not	lactation),	female	
offspring	 gained	 less	 weight	 and	 fat	 mass	 on	 HFD	 and	
male	 offspring	 had	 improved	 lipid	 profiles.46  Maternal	
metformin	 also	 prevented	 the	 worsening	 glucose	 toler-
ance	normally	seen	after	7 weeks	of	HFD	feeding,	 sug-
gesting	 offspring	 were	 protected	 against	 HFD-	induced	
obesity	 and	 glucose	 intolerance	 in	 adulthood.46  These	
contrasting	 results	highlight	 the	 importance	of	 the	ma-
ternal	metabolic	state	with	regard	to	offspring	outcome.	
A	latter	study	by	the	same	group	using	a	genetic	model	
of	 obesity	 (selective	 NPY	 overexpression	 in	 the	 brain	




to	 confirming	 the	 importance	 of	 the	 maternal	 environ-
ment	 in	 determining	 offspring	 response	 to	 metformin,	















male	 offspring	using	 a	 similar	 model	 in	 the	 rat.49  These	
studies	provided	metformin	treatment	during	both	preg-
nancy	 and	 lactation,	 which	 differs	 from	 human	 clinical	
settings.	The	only	 study	 to	date	 investigating	gestational	
(but	 not	 lactational)	 metformin	 treatment	 in	 obese	 glu-
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6 	 | 	 CONCLUSION
In	conclusion,	animal	models	provide	an	extremely	use-
ful	tool	to	study	offspring	outcomes	in	models	of	develop-
mental	 programming	 by	 maternal	 obesity	 and/or	 GDM.	
Specifically,	 they	are	able	to	address	causality,	allow	the	
longitudinal	 assessment	 of	 cardiometabolic	 outcomes	
across	 the	 life-	course	and	 the	 investigation	of	 sex	differ-
ences,	and	they	can	help	determine	the	critical	windows	
during	 which	 offspring	 are	 particularly	 vulnerable	 to	
programming	 effects.	 Moreover,	 the	 evidence	 presented	
highlights	 the	 importance	of	addressing	both	short-	and	
long-	term	effects	of	interventions	on	both	mother	and	off-
spring.	 Animal	 studies	 therefore	 provide	 an	 ethical	 first	
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